Prescribing practices among psoriasis experts for patients with concomitant malignancy: a survey of International Psoriasis Council members
This study highlights significant variability in prescribing practices and a strong preference for biologics such as anti-IL-17 agents and apremilast. The findings underscore the urgent need for malignancy-specific guidelines informed by robust long-term safety data to support optimal decision making and improve patient outcomes.
Authors
- Caitriona Ryan (ORCID: https://orcid.org/0000-0003-1915-546X)
- Michelle Murphy
- Stephanie Bowe (ORCID: https://orcid.org/0000-0002-4958-820X)
- John Bourke
Institutions
- South Infirmary Victoria University Hospital (IE)
- Institute of Dermatology (TH)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1093/ced/llaf198
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.80